Cytogenetic abnormalities and associated efficacy from a phase III study comparing alemtuzumab vs. chlorambucilas first line therapy for B-cell chronic lymphocytic leukemia

被引：0
|
作者：
Robak, T.
Skotnicki, A.
Dmoszynska, A.
Hebert, J.
Wang, Y.
Belkaci, M.
Sirard, C.
Mayer, J.
Hillmen, P.
机构：
[1] Kopernik Mem Hosp, Lodz, Poland
[2] Jagiellonian Univ, Coll Med, Krakow, Poland
[3] Clin Hosp No 1, Lublin, Poland
[4] Cirion BioPharma Res Inc, Laval, PQ, Canada
[5] Genzyme, Cambridge, MA USA
[6] Univ Hosp Brno, Brno, Czech Republic
[7] Leeds Gen Infirm, Leeds, W Yorkshire, England
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0128
引用
收藏
页码：46 / 46
页数：1
相关论文
共 50 条
  • [21] Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival
    Moreton, P
    Kennedy, B
    Lucas, G
    Leach, M
    Rassam, SMB
    Haynes, A
    Tighe, L
    Oscier, D
    Fegan, C
    Rawstron, A
    Hillmen, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) : 2971 - 2979
  • [22] Interphase fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia.
    Xu, W
    Li, JY
    Pan, JL
    Li, L
    Qiu, HR
    Xue, YQ
    Ruan, CG
    BLOOD, 2005, 106 (11) : 329B - 329B
  • [23] JAPANESE B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - A CYTOGENETIC AND MOLECULAR BIOLOGICAL STUDY
    ASOU, H
    TAKECHI, M
    TANAKA, K
    TASHIRO, S
    DOHY, H
    OHNO, R
    KAMADA, N
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 85 (03) : 492 - 497
  • [24] UNIQUELY ALTERED RESIDUAL B-CELL PROFILES ARE ASSOCIATED WITH THE TRANSITION BETWEEN MONOCLONAL B-CELL LYMPHOCYTOSIS VS. CHRONIC LYMPHOCYTIC LEUKEMIA.
    van Dongen, Jacques J. M.
    Blanco, Elena
    Rodriguez-Caballero, Arancha
    Alcoceba, Miguel
    Contreras, Teresa
    Laura Gutierrez, Maria
    Romero, Alfonso
    Fernandez-Navarro, Paulino
    Gonzalez, Marcos
    Solano, Fernando
    Gomez, Carlos
    Perez-Andres, Martin
    Criado, Ignacio
    Almeida, Julia
    Orfao, Alberto
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 : 149 - 149
  • [25] Fludarabine and alemtuzumab versus fludarabine and rituximab in the treatment of relapsed B-cell chronic lymphocytic leukemia: Results from a phase II study.
    Gribben, J
    Stephans, K
    Marshal, B
    BLOOD, 2005, 106 (11) : 343B - 343B
  • [26] Bendamustine Versus Chlorambucil as First-Line Treatment in B Cell Chronic Lymphocytic Leukemia: An Updated Analysis from An International Phase III Study
    Knauf, Wolfgang Ulrich
    Lissitchkov, Toshko
    Aldaoud, Ali
    Liberati, Anna
    Loscertales, Javier
    Herbrecht, Roul
    Juliusson, Gunnar
    Postner, Gerhard
    Gercheva, Liana
    Goranov, Stefan
    Becker, Martin
    Hoeffken, Klaus
    Huguet, Francoise
    Foa, Robert
    Merkle, Karlheinz
    Montillo, Marco
    BLOOD, 2008, 112 (11) : 728 - 728
  • [27] Efficacy and safety of alemtuzumab in patients with relapsed B-cell chronic lymphocytic leukemia after autologous stem cell transplantation.
    Dartigeas, C
    Degenne, M
    Senecal, D
    Roingeard, P
    Cendrie, C
    Delain, M
    Benboubker, L
    Linassier, C
    Watier, H
    Binet, C
    Colombat, P
    Cartron, G
    BLOOD, 2004, 104 (11) : 688A - 688A
  • [28] THE EFFICACY OF FLUDARABINE AND CYCLOPHOSPHAMIDE COMBINATION IN UNTREATED VS PRETREATED PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
    Milosevic, V.
    Bogunovic, M.
    Jankovic, S.
    Antic, D.
    Tomin, D.
    Todorovic, M.
    Kurtovic, N. Kraguljac
    Jovanovic, M. Perunicic
    Bogdanovic, A.
    Mihaljevic, B.
    Gotic, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 527 - 527
  • [29] Randomized phase II study in untreated B-cell chronic lymphocytic leukemia (B-CLL) comparing fludarabine (FAMP) vs. high dose continuous chlorambucil (HD-CLB).
    Jaksic, B
    Brugiatelli, M
    Suciu, S
    Baumelou, E
    Wijermans, PW
    Delmer, A
    Roozendaal, KJ
    Teixeira, A
    Jehn, U
    Feremans, W
    Belhabri, A
    Venditti, A
    Indrak, K
    Rodts, P
    Solbu, G
    Willemze, R
    BLOOD, 1998, 92 (10) : 103A - 103A
  • [30] Epstein-Barr virus-positive lymphoma after alemtuzumab therapy for B-cell chronic lymphocytic leukemia
    Ammatuna, Emanuele
    Sarlo, Chiara
    Ottaviani, Licia
    Quaresima, Micol
    Buccisano, Francesco
    Campagna, Selenia
    Del Principe, Maria Ilaria
    De Angelis, Gottardo
    Anemona, Lucia
    Gumenyuk, Svitlana
    Amadori, Sergio
    Venditti, Adriano
    LEUKEMIA & LYMPHOMA, 2009, 50 (05) : 857 - 858
12345